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Abstract
Background: Allergic rhinitis is a common disease whose genetic basis is incompletely explained. We report an
integrated genomic analysis of allergic rhinitis.
Methods: We performed genome wide association studies (GWAS) of allergic rhinitis in 5633 ethnically diverse North
American subjects. Next, we profiled gene expression in disease-relevant tissue (peripheral blood CD4+ lymphocytes)
collected from subjects who had been genotyped. We then integrated the GWAS and gene expression data using
expression single nucleotide (eSNP), coexpression network, and pathway approaches to identify the biologic
relevance of our GWAS.
Results: GWAS revealed ethnicity-specific findings, with 4 genome-wide significant loci among Latinos and 1
genome-wide significant locus in the GWAS meta-analysis across ethnic groups. To identify biologic context for
these results, we constructed a coexpression network to define modules of genes with similar patterns of CD4+ gene
expression (coexpression modules) that could serve as constructs of broader gene expression. 6 of the 22 GWAS loci
with P-value≤1x10
−6 tagged one particular coexpression module (4.0-fold enrichment, P-value 0.0029), and this
module also had the greatest enrichment (3.4-fold enrichment, P-value 2.6× 10
−24) for allergic rhinitis-associated
eSNPs (genetic variants associated with both gene expression and allergic rhinitis). The integrated GWAS, coexpression
network, and eSNP results therefore supported this coexpression module as an allergic rhinitis module. Pathway analysis
revealed that the module was enriched for mitochondrial pathways (8.6-fold enrichment, P-value 4.5 ×10
−72).
(Continued on next page)
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Conclusions: Our results highlight mitochondrial pathways as a target for further investigation of allergic rhinitis
mechanism and treatment. Our integrated approach can be applied to provide biologic context for GWAS of other
diseases.
Keywords: Genome-wide association study, Allergic rhinitis, Coexpression network, Expression single-nucleotide
polymorphism, Coexpression module, Pathway, Mitochondria, Hay fever, Allergy
Background
Allergic rhinitis is an IgE-mediated inflammation of the
upper airway that causes naso-ocular congestion, pruri-
tis, rhinorrhea, and sneezing [1]. Colloquially referred to
as hay fever, seasonal allergies, and allergies, allergic
rhinitis is one of the most common chronic diseases, af-
fecting up to 30% of adults and 40% of children [1].
A genetic contribution to allergic rhinitis is evident,
based on an increased incidence and prevalence of aller-
gic rhinitis among twins and within atopic families [2,3].
Despite the high population prevalence of allergic rhin-
itis, there have been relatively few studies of its genetic
basis. The National Human Genome Research Institute
catalogs just one genome wide association study (GWAS)
of allergic rhinitis [4], for example, compared to 33 for
asthma and 61 for diabetes [5]. Candidate gene studies
have been performed with variable effect sizes and levels
of significance reported [3,6,7]. We are aware of three
prior GWAS of allergic rhinitis. Andiappan et al. found no
genome-wide significant loci in a GWAS of allergic rhin-
itis in 942 Chinese subjects [8]. Ramasamy et al. reported
one genome-wide significant locus in a GWAS meta-
analysis of 12,898 Europeans [4]. Hinds et al. reported 16
genome-wide significant loci for self-reported allergy in a
GWAS meta-analysis of subjects of European ancestry [9].
The functional implications of the identified loci were
not directly examined in these studies. In a GWAS of
allergen-specific IgE level (i.e. not allergic rhinitis),
Bonnelykke et al. estimated that ten loci associated with
allergen-specific IgE level accounted for 25% population-
attributable risk for allergic rhinitis [10], but this was not
from a direct study of allergic rhinitis. Of note, loci associ-
ated with allergen-specific IgE level have not been consist-
ently associated with allergic rhinitis [4,9]. Given that the
genetic loci identified to date do not fully explain the esti-
mated heritability of allergic rhinitis, it is likely that as yet
unidentified genes and pathways contribute to allergic
rhinitis pathogenesis.
GWAS results on their own, while helping to elucidate
the etiology of disease, do not provide a rich context
within which to interpret any finding [11,12]. For ex-
ample, for disease-associated SNPs in intergenic regions,
the gene is not necessarily immediately known [13].
Typically the closest gene is identified as the gene of
interest, but that is not a foolproof algorithm, and the
pathways affected by the genetic locus are also not ne-
cessarily immediately apparent [13]. In addition, given
the stringent P value thresholds that must be adopted in
a GWAS to declare genome-wide significance, much of
the data in a GWAS that may inform on disease is ig-
nored because the association P values (and effect sizes)
that reflect true associations cannot be distinguished
from the noise [14].
Various methods have been tried to identify biologic
context for loci identified by GWAS, including (1) ex-
pression quantitative trait loci (eQTL) mapping and ex-
pression single nucleotide polymorphism (eSNP) analysis
[10,15-18], (2) network analysis [19,20], and (3) pathway
analysis [18,21-23]. eQTL mapping and eSNP analysis are
frequently used [15-18]. The motivation for eQTL map-
ping and eSNP analysis is that genetic variation is more
likely to impact a disease trait if it alters gene transcrip-
tion. Linkage or association methods can be used to
identify genetic loci influencing gene expression. The
linkage-based identification of loci for gene expression
is called eQTL mapping, and the association-based iden-
tification of SNPs affecting gene expression is called eSNP
analysis [15]. Because complex traits such as allergic rhin-
itis are unlikely to be governed by single genes or loci,
however, eQTL and eSNP analyses alone may provide
insufficient context. Network approaches can model
vast networks of gene interactions that modulate dis-
ease [19,20,24]. Networks are formed by considering
pairwise relationships between genes, including protein
interaction relationships and coexpression relation-
ships [14,24]. Considering GWAS results in the con-
text of whole-gene networks may thus provide the
necessary context within which to interpret the disease
role for a given gene or variant identified by GWAS.
Finally, pathway analysis can help decipher the func-
tional implications of coherent groups of genes with re-
spect to gene ontology functional categories [18,21-23].
Pathways representing specific biologic mechanisms may
be overrepresented in genes identified by GWAS, thereby
providing relevant biologic context for GWAS results.
Among all GWAS, some have reported findings with-
out characterizing the effects of loci on gene expression
and downstream biologic pathways [4,8,25], while others
have incorporated eQTL/eSNP, network analysis, and
pathway analysis individually to provide some evidence
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proaches have elucidated biologic mechanisms and treat-
ment targets in a number of disease areas including
inflammatory bowel disease, Alzheimer’s disease, dia-
betes, heart disease, and obesity [15,24,26-29], but simi-
lar strategies have not been widely applied to allergy.
Further, the gene expression data used to support many
GWAS are drawn from individuals distinct from those
who were genotyped [16,18,19,21,23], rendering the ana-
lysis of any effects of genotype on gene expression indir-
ect and potentially biased due to differences in subjects
who were genotyped versus subjects with mRNA data.
For example, while Hinds et al. performed GWAS to
identify allergy-related loci in a sample of personal gen-
etics company customers and birth cohort participants
[9], they then identified expression quantitative trait loci
(eQTL) among these loci using monocyte gene expres-
sion data from a distinct study cohort of heart disease.
We hypothesized that a genome-wide approach to al-
lergic rhinitis integrating GWAS with eSNP, coexpres-
sion, and pathway analyses using gene expression data
generated from disease-relevant tissue collected from
the same individuals who were genotyped could enhance
the power over standard GWAS to identify disease-
relevant loci. Such an approach could not only provide
more robust biological context, but also leverage data
from cohorts that may not be large enough to yield high
numbers of genome-wide significant GWAS results for
complex traits such as allergic rhinitis. Here we present
our integrated genomic analysis of allergic rhinitis,
where we not only identified genome-wide significant
genetic variants associated with allergic rhinitis, but
also explored the biologic context for these results by
profiling gene expression from CD4+ lymphocytes col-
lected from genotyped subjects and performing expres-
sion single nucleotide polymorphism (eSNP), network,
and pathway analyses. Our integrated approach identi-
fied a novel pathway in allergic rhinitis.
Results
Our integrated genomic analysis of allergic rhinitis yielded
results from GWAS, gene expression profiling, and their
integrated analysis (Figure 1). We first describe the results
of our GWAS of allergic rhinitis in 5633 ethnically diverse
North American subjects, where we identified genome-
wide significant loci that were specific to ethnicity
(Figure 1, pink box). We then describe the results of
our gene expression profiling of immune cells key to
allergy (CD4+ lymphocytes [30]), collected from the
peripheral blood of selected subjects who had under-
gone GWAS (Figure 1, blue box). We share the results
for the weighted gene coexpression network [31] we
constructed to identify modules of genes expressed to-
gether. Finally, we describe the integration of our
GWAS and gene expression analyses (Figure 1, purple
box), where we performed eSNP analysis to assess for
the association between genetic variation and gene ex-
pression (Figure 1, purple path), assessed GWAS loci
for eSNPs (Figure 1, turquoise path), identified coexpres-
sion modules tagged by GWAS loci (Figure 1, orange
path), and analyzed coexpression modules for enrichment
of allergic-rhinitis associated eSNPs (Figure 1, green path)
[15]. We then used pathway analysis to further inform on
the biological context for our integrated findings.
GWAS
Subject characteristics
The baseline characteristics of the participating subjects
are shown in Table 1. In total, there were 5633 subjects
from 7 EVE Consortium study centers [25] in the United
States, Mexico, and Barbados who were assessed for al-
lergic rhinitis. 2756 (49%) were female. Participants were
diverse, with 2034 (36%) European American, 2326
(41%) Latino, and 1273 (23%) African American/African
Caribbean. The overall prevalence of allergic rhinitis
cases was 48% (2712 subjects).
GWAS and meta-analysis
Because subjects were ethnically diverse, we pooled
genotype data from the 7 study centers into three ethnic
groups for GWAS: European American, Latino, and
African-American/African Caribbean (Figure 1, pink
box) and controlled for population stratification within
each ethnic group using principal components. Figure 2
shows the results of genome-wide association studies for
allergic rhinitis among European Americans, Latinos,
and African-American/African-Caribbeans, in addition
to the results of the meta-analysis across these ethnic
groups. For additional views, Additional file 1: Figure S1
shows the Manhattan plots separately for each ethnic
group and for the meta-analysis. There were distinct
findings for each ethnic group. Figure 3 summarizes
the results for the 22 loci with P value for associ-
ation ≤ 1×10
−6 in at least one of the ethnic groups or in
the meta-analysis. We show loci meeting this threshold to
include loci with suggestive associations (P value≤1×1 0
−6)
in addition to those genome-wide significant (defined as P
value ≤5×10
−8), as loci not meeting strict definitions of
genome-wide significance can have biologic relevance
[11,12]. Allele frequencies are shown in Additional file 2:
Table S1, and a QQ plot for the GWAS meta-analysis is
shown in Additional file 3: Figure S2. The genomic inflation
factor was 1.06, supporting adequate control for population
stratification.
Four loci on chromosomes 2p22.3 near LINC0048,
3q29 near DLG1, 10p15.1 near AKR1E2, and 19q13.43
near ZNF776 were genome-wide significant among Lati-
nos (Figure 3). The regional association plots for these
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text, each of these SNPs was directly genotyped in 2 of
the 7 populations, imputation was performed using very
conservative metrics [25], and the imputation scores for
these SNPs demonstrated good confidence (Additional
file 5: Table S2). The regional LD plots for these loci
(Additional file 6: Figure S4) show that there were lim-
ited SNPs in LD with these genome-wide significant loci.
The locus marked by rs7780001 on chromosome 7p21.1
near FERD3L was genome-wide significant in the meta-
analysis across ethnic groups (P value 2.0 × 10
−8; Figure 3
and Additional file 7: Figure S5) and had nominally signifi-
cant associations in all three ethnic groups. The loci marked
by rs2884670 on chromosome 12p13.32 near DYRK4 and
rs7237244 on chromosome 18q11.2 near LAMA3 also had
nominally significant associations in all three ethnic groups.
Among the 17 loci previously identified by GWAS as asso-
ciated with allergic rhinitis [4,9], four were associated
with allergic rhinitis with P value≤ 0.05 in our study
(Additional file 8: Table S3).
Individuals with allergic rhinitis frequently have co-
morbid asthma [1,32]. Indeed, we observed that 2051
(76%) of those with allergic rhinitis had asthma, and
1195 (41%) of those without allergic rhinitis had asthma.
As subphenotypes of AR based on asthma status are
possible, we also performed secondary GWAS stratified
by asthma status. These results are shown in the sup-
plementary file (Additional file 9: Supplementary Re-
sults 1, Additional file 10: Table S4, and Additional file 11:
Figure S6) and similarly showed ethnicity-specific findings.
In Additional file 12: Table S5, we show the sample compos-
ition of the stratified analyses according to asthma status.
Figure 1 Study flow for the integrated genome-wide association, coexpression network, and expression single nucleotide polymorphism
analysis of allergic rhinitis. CHS=Children’s Health Study, CAMP=Childhood Asthma Management Program, CAG=Chicago Asthma Genetics
Study, CSGA=Collaborative Studies on the Genetics of Asthma, SARP=Severe Asthma Research Program, GALA1=Genetics of Asthma in Latinos,
MCCAS=Mexico City Childhood Asthma Study, GRAAD=Genomic Research on Asthma in the African Diaspora and Barbados, SAPPHIRE=Study of
Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity. Detailed descriptions of the individual studies have been previously
described [25].
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network to enhance GWAS
To assess the potential biological impact of the loci identified
in our GWAS analyses, we collected and measured genome-
wide gene expression in disease-relevant tissue (peripheral
blood CD4+ lymphocytes) from 200 subjects who had
undergone GWAS and constructed a gene coexpression net-
work based on the gene expression data (Figure 1, blue box).
We built the coexpression network to identify coexpressed
gene modules (i.e. groups of genes with similar patterns
of expression profiles and interconnectivity across the
experimental samples), as these could serve as broader
constructs of gene expression and provide a path to
discover broader biologic context [31].
We achieved CD4+ lymphocyte yields of ~4x10
6 cells
at ≥95% purity per collection. Bioanalyzer (Agilent Tech-
nologies, Santa Clara, CA) analysis confirmed average
total RNA yields of 2 μg per collection, with minimal
evidence of RNA degradation and 28S:18S ratios ap-
proaching 2.0.
Figure 4A shows the coexpression network we con-
structed using weighted gene coexpression network analysis
Table 1 Baseline characteristics of North American subjects included in the study
Study
a
CHS CAMP CAG/CSGA/SARP GALA1 MCCAS GRAAD SAPPHIRE
Number 2881 384 283 521 476 809 279
Age (years) 8.3 (5.2-14.3) 8.8 (5.2-13.2) 27.3 (6.0-81.0) 14.8 (8.0-40.0) 9.0 (5.0-17.0) 40.0 (14.0-84.0) 30.3 (12.0-56.0)
Female 1344 (47%) 142 (37%) 150 (53%) 230 (44%) 198 (42%) 474 (59%) 219 (78%)
Race
European American 1552 (54%) 384 (100%) 98 (35%)
Latino 1329 (46%) 521 (100%) 476 (100%)
African American/African Caribbean 185 (65%) 809 (100%) 279 (100%)
Allergic Rhinitis 1096 (38%) 199 (52%) 245 (87%) 434 (83%) 250 (53%) 377 (47%) 111 (40%)
Asthma 1206 (42%) 384 (100%) 283 (100%) 521 (100%) 476 (100%) 228 (28%) 148 (53%)
Genotyping platform
b 550 K, 610 K 550 K 1Mv1 6.0 550 K 650 K 6.0
Values are mean (range) or number (percent).
aCHS = Children’s Health Study, CAMP = Childhood Asthma Management Program, CAG = Chicago Asthma Genetics Study, CSGA = Collaborative Studies on the
Genetics of Asthma, SARP = Severe Asthma Research Program, GALA1=Genetics of Asthma in Latinos, MCCAS=Mexico City Childhood Asthma Study, GRAAD=Genomic Research
on Asthma in the African Diaspora and Barbados, SAPPHIRE= Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity. Detailed descriptions of the individual
studies have been previously described [25].
bThe Illumina arrays used were the 1Mv1, 550 k, 610 k and 650 k. The Affymetrix arrays used were the 500 k and 6.0.
Figure 2 Manhattan plot of the genome-wide association and meta-analysis results for allergic rhinitis showing ethnicity-specific
findings.
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were 41 coexpressed gene modules identified by the coex-
pression network, and their interconnectivities are shown.
For ease of visualization, modules are identified by color.
Using pathway analysis, we found that the modules
were enriched for a variety of gene ontology (GO) path-
ways reflecting the functions being carried out by each
module. Pathways associated with the largest coexpres-
sion modules are shown in the legend of Figure 4A. For
example, the brown module highlighted in Figure 4B
was enriched for mitochondrial function. Zinc finger, in-
flammatory response, and immunoglobulin domain were
other pathways highlighted by examining the coexpres-
sion modules for functional enrichment (Figure 4A).
Integration of GWAS and CD4+ gene expression to
explore biologic context for GWAS
To explore the biologic context for our GWAS results,
we analyzed our GWAS and gene expression findings
together (Figure 1, purple box).
GWAS loci that are eSNPs
We first performed eSNP analysis to assess for the asso-
ciation between genetic variation and gene expression
(Figure 1, purple path). We then examined the GWAS
and eSNP results together to identify GWAS loci that
were eSNPs (Figure 1, turquoise path), as genetic vari-
ation that is associated with both the trait and gene
expression is more likely to be biologically relevant than
variants that are associated with the trait only with no
effect on gene expression. We found that the 19q13.43
locus near ZNF776 was associated with allergic rhinitis
(GWAS P value 5.0 × 10
−8) as well as CD4+ gene ex-
pression (χ
2= 19.55, FDR-adjusted P value 0.00078). The
other loci identified by GWAS were not associated with
CD4+ gene expression.
Given the relatively modest size of our sample and the
fact that we were examining a complex trait, we had an-
ticipated that traditional GWAS would uncover only a
small number of biologically relevant loci, even with the
aid of eSNP analysis, as such an approach would rely
upon detection of single variant associations with trait
and expression. We therefore sought to leverage the
CD4+ expression data more broadly through coexpres-
sion network and pathway analysis.
Coexpression modules tagged by GWAS loci
Compared to individual genes, coexpression modules
identified through coexpression network analysis (Figure 4)
can serve as more general constructs of gene expression,
providing a path to discover broader context and related
loci [14,28,31,33-40]. Motivated by the same rationale that
genetic variation that is associated with both the trait and
gene expression is more likely to be biologically relevant
than variants associated with the trait only, we mapped
GWAS loci to CD4+ coexpression modules and examined
Figure 3 Results of the genome-wide association studies of allergic rhinitis, meta-analysis, and GWAS tagging of the coexpression
network.
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ange path). Specifically, we defined a GWAS locus as tag-
ging a coexpression module if a coexpression module
contained a gene within 250 kb of the locus. We found
that 9 of the 22 GWAS loci tagged at least one coex-
pression module and 6 coexpression modules in total
(Figure 3). These 6 modules (the brown, pink, magenta,
red, midnight blue, and steel blue coexpression modules)
tagged by GWAS loci were therefore considered candidate
allergic rhinitis associated modules that could inform on
allergic rhinitis biology. The 19q13.43 locus near ZNF776
was among the GWAS loci tagging coexpression modules,
corroborating our eSNP results and illustrating the in-
creased power of detection gained by using the coex-
pression module as a more general construct of gene
expression. Of note, some of candidate allergic rhinitis
associated modules were tagged by GWAS loci that
would not have been considered remarkable by trad-
itional criteria for genome-wide significance of individ-
u a ll o c i( Pv a l u e ≤ 5.0 × 10
−8). Our approach of using
GWAS loci to tag coexpression modules therefore
allowed us to gain additional utility from our GWAS
results.
Among the 6 candidate allergic rhinitis associated mod-
ules tagged by GWAS loci, the brown module (represent-
ing mitochondrial pathways according to pathway analysis
(Figure 4)) was tagged by 6 of the 22 GWAS loci (Figure 3).
This proportion represented a significant enrichment
(4.0-fold enrichment, P-value 0.0029) over chance, sup-
porting a connection between these GWAS loci and mito-
chondrial pathway functions.
Coexpression module enrichment for allergic rhinitis-associated
eSNPs
To further ascertain whether any of the 6 candidate
allergic rhinitis associated modules were underlying
allergic rhinitis susceptibility, we tested whether these
modules were enriched for eSNPs that were also associ-
ated with allergic rhinitis (Figure 1, green path). eSNPs
(i.e. SNPs associated with gene expression) represent
functionally validated SNPs of interest in that they are
associated with expression levels of genes in a cell type
relevant to the disease under study [15]. While such
individual associations may not be meaningful, the
pattern of associations enriched within a given coex-
pression module can provide strong statistical support
for module involvement at the genetic level in the disease
[14,28,31,33-40]. The additional association of eSNPs
within a coexpression module with the disease of interest
provides further statistical support that the coexpression
module is involved in the disease, as the module is then
not only enriched for eSNPs (e.g. SNPs associated with
CD4+ gene expression), but more specifically, enriched
for disease-associated eSNPs (e.g. SNPs associated with
both CD4+ gene expression and allergic rhinitis).
In this instance, we identified the brown module as giv-
ing rise to the greatest enrichments of allergic-rhinitis-
associated eSNPs (3.4-fold enrichment; FDR-adjusted
Fisher’s Exact Test P value 2.6×10
−24) (Figure 5), thus
providing statistical support for involvement of the brown
module in allergic rhinitis. Pathway analysis revealed that
the brown module was enriched for mitochondrial path-
ways (8.6-fold enrichment, FDR-adjusted Fisher Exact
(See figure on previous page.)
Figure 4 CD4+ lymphocyte coexpression network with detail of the brown coexpression module. A. Each circle represents a gene.
Weighted gene coexpression analysis identified groups of genes with similar patterns of gene expression and interconnectivity (coexpression
modules). The 41 coexpression modules identified are labeled by color. Pathways associated with the largest coexpression modules are denoted
in the legend. B. Interconnectivity of the brown coexpression module is shown in detail. Tagged by 6 allergic rhinitis GWAS loci, this
coexpression module was highly enriched for allergic rhinitis-associated eSNPs (3.4-fold enrichment, FDR-adjusted P value= 2.6×10
−24) and also
highly enriched for pathways related to mitochondrial function (8.6-fold enrichment, FDR-adjusted P value =4.5 × 10
−72). Genes containing
allergic rhinitis-associated eSNPs are marked in brown, with those containing eSNPs with lowest P-value for association between genotype
and gene expression marked with greatest brown saturation. Genes in pathways related to mitochondrial function are marked by diamonds with
blue outline. Higher correlation between gene expression is shown with thicker and darker edges.
Figure 5 eSNP enrichment and pathway analysis of coexpression modules tagged by GWAS loci.
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−72) (Figure 5 and Figure 4B). The
red and midnight blue modules were also enriched for
allergic rhinitis–associated eSNPs, and both these mod-
ules were enriched for mitochondrial pathways as well
(Figure 5). The pink module, enriched for the GO term
intracellular organelle lumen, functionally overlaps with
mitochondrial pathway. Thus, the candidate allergic
rhinitis-associated modules were all significantly enriched
for allergic rhinitis-associated eSNPs, and pathway ana-
lysis results for at least half of these modules highlighted
mitochondrial pathways as linked to allergic rhinitis. Re-
sults from randomized networks did not yield meaningful
results (Additional file 13: Supplementary Results 2,
Additional file 14: Figure S7).
In summary, pathway analysis of our results from the
integration of GWAS and coexpression network analysis
(showing a significantly high number of GWAS loci tag-
ging the brown module), as well as from the integration
of eSNP analysis and coexpression network results
(showing greatest enrichment of the brown module for
allergic rhinitis-associated eSNPs), both pointed to mito-
chondrial pathways as playing an important role in aller-
gic rhinitis (Figure 1). Key to these results was that the
coexpression network helped organize the expression
traits into coherent, highly interconnected modules reflect-
ing the biological processes at play in the tissue. By using
GWAS loci to tag coexpression modules and then requir-
ing these tagged coexpression modules to be enriched for
eSNPs that were also associated with allergic rhinitis, we
were able to place candidate GWAS associations in a more
informed context that not only provided a biological con-
text for GWAS interpretation, but enhanced confidence in
the suggestive hits given an enrichment of multiple func-
tional SNPs associating with the disease phenotype [15].
Through this approach, we found consistent evidence that
mitochondrial pathways likely play a role in the genetics
and pathophysiology of allergic rhinitis.
Discussion
A motivation for genome-wide studies is the desire to
identify novel pathways and mechanisms in disease
pathogenesis. A limitation of traditional genome-wide
association studies is that statistically significant loci
may be identified [4,9], but the biological relevance of
the individual or aggregate variants are often not evident
[11,12]. This is not overcome by replication of genotype
associations, which has been the usual path taken to fol-
low up GWAS findings, and one which has led to limited
success [7,9,41]. Our study demonstrates the advantages
of integrating network approaches with GWAS to identify
and prioritize pathways and gene targets of biologic rele-
vance. By integrating our GWAS findings with eSNP,
coexpression, and pathway analyses using gene expression
data from disease-relevant tissue generated from
subjects who had undergone GWAS, we tested the po-
tential biologic context of our GWAS findings through
integrative methods and identified a novel pathway in
allergic rhinitis—mitochondrial pathways. Our method
a l l o w e du st ol e v e r a g ed a t af r o mm u l t i p l eG W A Sl o c i
to identify biologic context for the aggregate findings.
This is in contrast to traditional GWAS, where the im-
plications of individual SNP associations are often
challenging to define [11,12]. Because complex traits
such as allergic rhinitis are unlikely to be governed by
single variants, strategies that capitalize on broader
constructs of GWAS and gene expression results are
more likely to yield informative disease context. We
adopted such a strategy and were able to identify novel
biologic context for allergic rhinitis. Further, our ap-
proach of integrating genotype and gene expression
data generated from the same sample has not been
widely applied to the study of allergic diseases. Our
methods can be used to provide a richer biologic con-
text for GWAS findings in other disease areas.
While mitochondrial pathways have not been associ-
ated with allergic rhinitis pathogenesis in traditional de-
scriptions [1] or genetic studies of the disease [4,8,9],
our findings and those from laboratory-based studies of
airway dysfunction support a role for mitochondrial
perturbations in allergic rhinitis pathogenesis. There is a
strong link between upper (e.g. nasal) and lower (e.g. bron-
chial) airway disease pathogenesis [42], and mitochondrial
perturbations have been observed to affect airway inflam-
mation. Mitochondria are the major source of endogenous
reactive oxygen species, which are required for normal
function of the acquired immune response, including nor-
mal T-cell activation, B-cell differentiation, and T-cell and
B-cell proliferation [43]. Because alterations in the acquired
immune response are observed in allergic inflammation
and allergic rhinitis, mitochondrial disruption could play a
role in allergic rhinitis. There are some experimental data
in support of this hypothesis. OVA-induced allergic airway
inflammation in BALB/c mice triggers mitochondrial dys-
function, including the reduction of cytochrome c oxidase
activity in lung mitochondria, reduction in the expression
of subunit III of cytochrome c oxidase in bronchial epithe-
lium, appearance of cytochrome c in lung cytosol, and
mitochondrial ultrastructural changes such as loss of cris-
tae and swelling [44]. Experiments using pollen, rather
than ova, to induce allergic inflammation more akin to al-
lergic rhinitis in humans, have also shown mitochondrial
disturbance. Pollen grains and subpollen particles have
intrinsic NADPH oxidases [45]. Upon hydration in the air-
way epithelium they produce reactive oxygen species that
induce oxidative stress [46]. The pollen-induced oxidative
stress damages mitochondrial respiratory chain proteins
(specifically NADH dehydrogenase Fe-S protein (NDUFS)
and ubiquinol-cytochrome c reductase core (UQCRC)) in
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species production from mitochondrial respiratory chain
complex III, and induces mitochondrial dysfunction in
complex III [47].
Mitochondrial changes induced by pollen can serve as the
second hit leading to allergic inflammation if there is preex-
isting mitochondrial dysfunction. Indeed, when treated in-
tranasally with pollen extract, mice with mitochondrial
dysfunction (induced deficiency in UQCRC2) demonstrated
evidence of allergic airway inflammation, in contrast to
UQCRC2-sufficient control mice challenged with the
same pollen extract [47]. Specifically, these mice with
mitochondrial dysfunction exhibited a 4.4 fold increase
in bronchoalveolar lavage eosinophil counts, increased
accumulation of peribronchial inflammatory cells, en-
hanced mucous cell metaplasia in airway epithelium, and
increased airway hyperresponsiveness [47]. Although these
studies characterized changes in the lower airway, the
strong link between upper and lower airway disease patho-
genesis [42] suggests that analogous changes in the upper
airway could cause individuals with preexisting mitochon-
drial dysfunction to develop allergic inflammation leading
to allergic rhinitis with pollen exposure. Our results high-
light this as a potential mechanistic area, as 27% (6/22) of
the genetic loci for allergic rhinitis that we identified by
genome-wide association analysis tagged a gene coexpres-
sion module that was not only markedly enriched for
eSNPs associated with allergic rhinitis (3.4-fold, FDR-
adjusted P-value 2.6× 10
−24), but also significantly enriched
for mitochondrial pathways by pathway analysis (8.6-fold
enrichment, FDR-adjusted P value 4.5 ×10
−72).
Population-based studies additionally support a role for
mitochondrial pathways in allergic rhinitis pathogenesis.
Mitochondria are the primary sites of oxidative reactions.
Levels of malondialdehyde (a marker of oxidative stress)
are higher, and levels of reduced glutathione (an antioxi-
dant) are lower in the exhaled nasal condensates of aller-
gic rhinitis subjects compared to healthy controls [48].
The epidemiological link between maternal history of
atopy (as opposed to paternal history of atopy) and greater
risk for allergic rhinitis in offspring [49,50] may be ex-
plained by the fact that mitochondria are maternally trans-
mitted. Consistent with this, mitochondrial haplotypes are
associated with intermediate phenotypes of allergic rhin-
itis, including total serum IgE levels and skin prick test re-
activity [51].
Our results suggest that reducing mitochondrial dys-
function could improve allergic rhinitis. In murine models
of allergic airway inflammation, intratracheal administra-
tion of an antioxidant known to enter mitochondria and
protect the electron chain from oxidative damage [52] de-
creased allergen-induced airway hyperreactivity and air-
way inflammation severity, as shown by reduced numbers
of inflammatory cells in bronchoalveolar fluid [53]. Again,
these studies focused on lower airway disease, but the
strong link between upper and lower airway disease
pathogenesis [42] suggests that it may be possible to
achieve similar results if the upper airway were targeted in
allergic rhinitis treatment.
Our GWAS of allergic rhinitis was the first to examine
ethnically diverse subjects for this complex trait, and our
study revealed susceptibility loci that were specific to ethni-
city. This is consistent with genome-wide association stud-
ies of other complex diseases– such as asthma [25,54] and
obesity [55,56]– that have also demonstrated ethnicity-
specific effects. Given the possibility that allergic rhinitis
with comorbid asthma vs. allergic rhinitis without comor-
bid asthma may be distinct disease subphenotypes [32], we
also performed secondary GWAS analyses stratified by
asthma status. These results similarly showed ethnicity
specific findings. Our findings support the utility of
studying ancestrally-diverse populations in genome-wide
studies.
We recognize the limitations of our study. We defined
allergic rhinitis using criteria commonly employed in
population-based and genetic studies of allergic rhinitis,
which are based on questionnaire without objective
markers [1,4,9]. For our eSNP and coexpression network
analyses, it would have been ideal to have profiled gene ex-
pression for all 5633 subjects who participated in the
GWAS, but CD4+ lymphocytes were not available from all
subjects. We had CD4+ lymphocytes from European-
American CAMP subjects only, and it is possible that coex-
pression results would have differed had we additionally
had expression profiles from subjects of other ethnic back-
grounds, as gene expression can vary by ethnicity. While
expression differences can change with ethnicity, the
connectivity structure is expected to be much more highly
conserved, however, and is even seen across species [57].
Additionally, we recognize that our coexpression network
may have yielded distinct results had we chosen a different
tissue for gene expression profiling; we had chosen to study
peripheral blood CD4+ lymphocytes given their central role
in allergic disease [30]. Despite these limitations, we were
able to implement an integrative analysis of our GWAS,
coexpression network, and eSNP results, leading to the
identification of a novel biologic pathway in allergic rhinitis.
Our strategy created an informed biological context for our
G W A St h a tm a yb eu s e dt ob e t t e r understand allergic rhin-
itis. Further, our methods may be implemented to provide
biologic context for GWAS of other diseases.
Conclusions
Our GWAS of allergic rhinitis of 5633 ethnically diverse
subjects demonstrated ethnicity-specific, genome-wide
significant findings. To determine the potential biological
impact of the variants identified in our GWAS, we inte-
grated eSNP, coexpression network, and pathway analyses
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had undergone GWAS. Our integrated approach identified
mitochondrial pathways as important in allergic rhinitis, and
our strategy may prove useful to studying other diseases.
Methods
Ethics statement
Each study was approved by the Institutional Review
Board of the corresponding institution. Informed con-
sent was obtained for all study participants, and where
appropriate, informed assent from minors and informed
consent from their parent were obtained.
Subjects, genotyping, and phenotyping
Subjects were recruited from EVE Consortium centers in
the United States, Mexico, and Barbados. Detailed de-
scriptions of the individual studies, genotyping platforms,
and quality control protocols have been previously de-
scribed [25]. Of note, SNPs with imputation quality scores
below a threshold (Rsq<0.3) were removed from the ana-
lysis. We included subjects who were specifically assessed
for allergic rhinitis, and these came from 7 study centers
(Figure 1). Allergic rhinitis status was considered positive
if a subject reported a history of allergic rhinitis ever, de-
fined as hay fever or runny/stuffy nose with sneezing or
itching when the subject did not also have a cold or flu.
GWAS and meta-analysis
Summary files on a common set of SNPs were shared
among the EVE Consortium investigators. Genotype im-
putation using HapMap reference panels and Markov
Chain Haplotyping software (MaCH) [58] were per-
formed in each sample as previously described [25]. We
pooled the imputed genotype data for each ethnic group
(European American, Latino, African American/African
Caribbean) (Figure 1). To adjust for potential population
stratification, we used Eigenstrat [59] to create principal
components for each ethnic group. Within each ethnic
group, we tested for the association of SNPs with allergic
rhinitis by constructing a test statistic that had a stand-
ard normal distribution under the null hypothesis of no
association and captured the direction of the effect.
Models were implemented in PLINK [60] and controlled
for age, sex, and principal components. To allow for com-
parability with previous GWAS of allergic rhinitis [4,8,9],
we did not include asthma status as a covariate. To assess
for the effects of SNPs across ethnic groups, we then cal-
culated a meta-analysis statistic as a combination of the
individual ethnic study scores using METAL [61].
Recognizing the potential subphenotypes of isolated
allergic rhinitis vs. allergic rhinitis with comorbid asthma
[1,32], we additionally performed secondary GWAS and
meta-analyses in subjects stratified by asthma status
using methods analogous to the above.
Genome-wide CD4+ gene expression
We collected peripheral blood CD4+ lymphocytes from
200 subjects who had undergone GWAS. These 200
subjects were from Childhood Asthma Management Co-
hort (CAMP) cohort [62], one of the member centers of
the EVE Consortium (Figure 1). We focused on this
sample subset because of biospecimen availability. Per-
ipheral blood was collected into BD Vacutainer CPT
tubes (BD Diagnostics, Franklin Lakes, New Jersey) and
placed on ice. Samples were centrifuged within 1 hour
of collection for 20 minutes at 1700RCF, followed by
mononuclear cell layer isolation and suspension in 10 ml
of PBS. We isolated CD4+ lymphocytes using anti-CD4+
microbeads by column separation (Miltenyi Biotec,
Auburn, CA) using 20 μl anti-CD4+ Micro beads per 106
total cells. To extract total RNA, we used the RNeasy Mini
Protocol (QIAGEN, Valencia, CA) and stored at −80°C.
We generated expression profiles with the Illumina
HumanRef8 v2 BeadChip arrays (Illumina, San Diego
CA). Expression data were log2 transformed and quan-
tile normalized.
Coexpression network analysis
We performed weighted gene coexpression network ana-
lysis to identify coexpressed gene modules [31]. We used
a previously applied, well-established, well-recognized,
and validated method to construct the coexpression net-
work [14,28,31,33-40]. For module detection, we used
average linkage hierarchical clustering of a topological
overlap matrix based on an adjacency matrix that is
comprised of power-transformed correlations between
gene expression profiles [31]. To cut branches of the tree
into gene modules, we used the dynamic tree cutting al-
gorithm, which iteratively searches for stable branch
sizes and chooses clusters based on the shape of each
dendrogram branch [63]. This algorithm allows manipu-
lation of several parameters controlling the resultant
cluster size and cohesiveness. The modules identified
from the coexpression network were then carried for-
ward into the integrative analysis.
To provide support for the specificity of our coexpres-
sion network, we generated multiple random coexpres-
sion networks where gene assignments were randomized
(Random Networks 1–3), as well as random networks
where the gene expression levels were randomized
(Random Networks 4–6). We carried these random
networks forward into the integrated analysis as well.
Integration of GWAS and CD4+ gene expression
We defined a GWAS locus (P value for association
≤ 1×10
−6) as tagging a coexpression module if a
coexpression module contained a gene within 250 kb
of the locus. Coexpression modules tagged by GWAS
loci were identified as candidate allergic rhinitis
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of eSNPs that were also nominally associated with al-
lergic rhinitis. A SNP was considered an eSNP if the
SNP was located within 1 megabase of the corre-
sponding gene, and the association between genotype
and gene expression was significant at a 10% false
discovery rate (FDR) (P value≤ 1×1 0
−4). For modules
tagged by at least 1 GWAS locus, we used the
Fisher’s exact test to assess whether a module was
enriched for eSNPs that were also nominally associ-
ated (P value≤ 0.01) with allergic rhinitis. The com-
position of modules was then assessed by pathway
analysis using defined gene ontologies (GO) via the
DAVID analysis tool [64,65]. Overrepresentation of
canonical pathways and biological processes in modules
was measured via the Fisher’s exact test. P values from this
test were FDR-adjusted given the number of modules and
functional categories tested. Networks were visualized
using the Cytoscape network visualization tool [66].
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Additional file 1: Figure S1. Manhattan plots for the European
American, Latino, and African-American genome-wide association and
meta-analysis results for allergic rhinitis.
Additional file 2: Table S1. Allele frequencies for loci identified in the
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Additional file 3: Figure S2. QQ plot for the GWAS meta-analysis of
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significant locus (P value 1.0 × 10
−8) in the GWAS meta-analysis across
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